65,437 trials
Asthma
Primary: Change From Baseline in Asthma Quality of Life Questionnaire (AQLQ) Total Score — 0.715; 0.827; 0.753 Score on a scale — p=<0.001
Pacemaker
Primary: Complication Rate at 1-year Post-implant — 1.12 percentage of enrolled subjects
Prostate Cancer
Primary: The Number of Subjects With PSMA-positive (Prostate-specific Membrane Antigen) "Dominant" PC Lesion(s) Greater Than 5mm in Diameter, Whose Lesion(s) Have Been…
COPD Exacerbation
Primary: Time Until the First Exacerbation — 47; 48 days — p=<0.05
Glaucoma
Primary: Postoperative Intraocular Pressure — 14.6; 14.7 mmHg
Hematopoietic and Lymphoid Cell Neoplasm · Locally Advanced Malignant Solid Neoplasm · Locally Advanced Melanoma
Primary: Maximum-tolerated Dose (MTD) of Akt Inhibitor GSK2141795 in Combination With Dabrafenib. — 75 mg
Hepatitis B Vaccines
Primary: Geometric Mean Concentration (GMC) of Anti-HBs at Day 196 for Lot-to-Lot Consistency (Per Protocol Set 1) — 5883.93; 4824.06; 5505.98 mIU/ml
Depression · Major Depressive Disorder · Dysthymic Disorder
Primary: Brachial Artery Flow-Mediated Dilation (FMD) at 12 Months — 2.28; 2.44 % increase in brachial diameter — p=0.60
Facial Rejuvenation With Neurotoxins and/or Hyaluronic Acid Fillers
Primary: C-GAIS by the PI or Designee — 1.22; 2.13; 1.75; 2.75 units on a scale
Traumatic Brain Injury (TBI) · Hazardous and Harmful Alcohol Use
Primary: Change in the Number of Drinking Days Per Week as Assessed by the Timeline Followback (TLFB) — 2.2; 1.6 Drinking Days per week
Depression
Primary: Number of Participants With Response to Treatment — 58 Participants
Ulcerative Colitis
Primary: Percentage of Participants Who Achieved Clinical Remission Based on the Central Read of the Mayo Score (MS), at Week 8 — 6.2; 13.8; 16.4 Percentage of Participants…
Bipolar Disorder
Primary: Number of Participants With Response to Treatment" — 65 Participants
Asthma · Allergic Rhinitis
Primary: The Effect of Omnaris Nasal Spray & Alvesco Inhalation Aerosol vs Beconase AQ Nasal Spray & QVAR Inhalation Aerosol on Short-term Lower Leg Growth Velocity as Measured…
Myopia
Primary: Horizontal Lens Centration Assessed in Primary Gaze — -0.13; -0.04 millimeters